We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+6.04%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$932M
AUM Growth
+$28.1M
Cap. Flow
-$18.5M
Cap. Flow %
-1.98%
Top 10 Hldgs %
34.27%
Holding
222
New
12
Increased
42
Reduced
117
Closed
9

Top Buys

Rank Stock Value
1
ALC icon
Alcon
ALC
+$3.47M
2
AEO icon
American Eagle Outfitters
AEO
+$2.72M
3
BDX icon
Becton Dickinson
BDX
+$2.05M
4
RDFN
Redfin
RDFN
+$1.31M
5
NVO
Novo Nordisk
NVO
+$1.28M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$4.58M
2
MA icon
Mastercard
MA
+$2.99M
3
BIIB icon
Biogen
BIIB
+$2.95M
4
JNJ icon
Johnson & Johnson
JNJ
+$2.66M
5
ALV icon
Autoliv
ALV
+$1.32M

Sector Composition

Rank Sector Weight
1 Healthcare 28.85%
2 Technology 18.2%
3 Financials 12.25%
4 Industrials 12.07%
5 Communication Services 10.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HON icon
76
Honeywell
HON
$73.3B
$1.61M 0.17%
9,758
-663
-6% -$106K
NSC icon
77
Norfolk Southern
NSC
$75.1B
$1.6M 0.17%
8,018
-200
-2% -$39.7K
EFX icon
78
Equifax
EFX
$21.4B
$1.6M 0.17%
11,812
DXCM icon
79
DexCom
DXCM
$33.6B
$1.58M 0.17%
42,240
-1,440
-3% -$45.3K
IBM icon
80
IBM
IBM
$224B
$1.57M 0.17%
11,936
-3,704
-24% -$487K
AMGN icon
81
Amgen
AMGN
$224B
$1.57M 0.17%
8,514
-77
-0.9% -$13.8K
VUG icon
82
Vanguard Morningstar Growth ETF
VUG
$228B
$1.55M 0.17%
57,114
-90
-0.2% -$2.4K
VAR
83
DELISTED
Varian Medical Systems, Inc.
VAR
$1.45M 0.16%
10,635
-550
-5% -$73.5K
IONS icon
84
Ionis Pharmaceuticals
IONS
$9.3B
$1.42M 0.15%
22,110
+150
+0.7% +$10.6K
T icon
85
AT&T
T
$167B
$1.4M 0.15%
55,397
-1,334
-2% -$32K
ZTS icon
86
Zoetis
ZTS
$30.9B
$1.39M 0.15%
12,236
TFC icon
87
Truist Financial
TFC
$64.1B
$1.35M 0.15%
27,530
-3,680
-12% -$180K
ZUO
88
DELISTED
Zuora, Inc.
ZUO
$1.28M 0.14%
83,828
-59,554
-42% -$1.13M
CSX icon
89
CSX Corp
CSX
$92.8B
$1.28M 0.14%
49,530
-6,000
-11% -$155K
IJH icon
90
iShares Core S&P Mid-Cap ETF
IJH
$127B
$1.27M 0.14%
32,615
TWTR
91
DELISTED
Twitter, Inc.
TWTR
$1.25M 0.13%
35,903
-9,350
-21% -$343K
RDFN
92
DELISTED
Redfin
RDFN
$1.23M 0.13%
+68,315
New +$1.31M
ECL icon
93
Ecolab
ECL
$79.9B
$1.22M 0.13%
6,183
-1,040
-14% -$193K
EMR icon
94
Emerson Electric
EMR
$90.9B
$1.17M 0.13%
17,507
-833
-5% -$55.8K
AFL icon
95
Aflac
AFL
$61B
$1.15M 0.12%
21,032
-4,300
-17% -$222K
BMY icon
96
Bristol-Myers Squibb
BMY
$130B
$1.09M 0.12%
24,097
-1,165
-5% -$54.3K
BA icon
97
Boeing
BA
$185B
$1.07M 0.11%
2,928
-205
-7% -$74.8K
TMUS icon
98
T-Mobile US
TMUS
$193B
$1.02M 0.11%
13,712
KO icon
99
Coca-Cola
KO
$372B
$964K 0.1%
18,922
-195
-1% -$9.56K
BSX icon
100
Boston Scientific
BSX
$74.4B
$951K 0.1%
22,117
+116
+0.5% +$4.46K

Similar funds

Reynders McVeigh Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Reynders McVeigh Capital Management held 222 positions worth $932M, up 3.1% from $904M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Reynders McVeigh Capital Management's Q2 2019 filing shows 12 new, 42 increased, 117 reduced and 9 closed positions. Its largest new stake was Alcon: 59,134 shares worth $3.67M. The largest sale was Novartis, an estimated $4.58M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Technology and Financials.

  • Reynders McVeigh Capital Management's largest Q2 2019 buy was Alcon: 59,134 shares worth $3.67M.
  • Reynders McVeigh Capital Management added most to American Eagle Outfitters in Q2 2019, an estimated $2.72M increase.
  • Reynders McVeigh Capital Management's biggest Q2 2019 reduction was Novartis, cutting an estimated $4.58M.
  • Reynders McVeigh Capital Management fully exited Autoliv in Q2 2019, selling an estimated $1.32M.
  • Reynders McVeigh Capital Management's ten largest holdings make up 34% of its $932M portfolio in Q2 2019.
  • Reynders McVeigh Capital Management opened 12 new positions and closed 9 in Q2 2019.
  • Reynders McVeigh Capital Management's portfolio value rose 3.1% quarter-over-quarter to $932M.

Based on Reynders McVeigh Capital Management's 13F filing for Q2 2019, filed 6 Aug 2019.